Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | MMP13 | P45452 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7225149 | 0.92 | HTR4 (0.37) | SLC6A3SLC6A4SLC6A2NPC1RAB9A | |
| SCHEMBL7233323 | 0.90 | ESR1 (0.37) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL7223301 | 0.90 | MAPT (0.36) | SLC6A4RAB9AMMP13 | |
| SCHEMBL7225066 | 0.89 | SLC6A4 (0.41) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL7232095 | 0.89 | CHRNA7 (0.34) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL7225381 | 0.89 | HTR3E (0.37) | SLC6A3SLC6A4SLC6A2NPC1MMP13 | |
| SCHEMBL7231735 | 0.88 | MMP2 (0.36) | POLBP2RY14 | |
| SCHEMBL7231868 | 0.88 | SLC6A2 (0.41) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL7231419 | 0.88 | SCN9A (0.37) | SLC6A3SLC6A4SLC6A2NPC1RAB9A | |
| SCHEMBL7224931 | 0.88 | F2 (0.37) | MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6562816-B2 | Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects | PHARMACIA & UPJOHN COMPANY | 2003-05-13 | — | — | US | claimed |
| US-6562816-B2 | Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects | PHARMACIA & UPJOHN COMPANY | 2003-05-13 | — | — | US | disclosed |